Advertisement
For relatively healthy older individuals

Daily Low-Dose Aspirin Does Not Cut Dementia Risk in Seniors

0
Risks for dementia, probable Alzheimer disease, MCI not reduced by low-dose aspirin versus placebo
In a statement published online March 19 by the Infectious Diseases Society of America

IDSA Issues Recommendations for COVID-19 Testing

0
Four-tier approach prioritizes ICU patients, those with symptoms and contact with a patient or travel history
Inhibition of interleukin-1β with canakinumab is associated with reduced incident anemia as well as improved hemoglobin levels among patients with baseline anemia

Interleukin-1β Inhibition Linked to Reduced Incidence of Anemia

0
Among those with baseline anemia, hemoglobin levels improved with canakinumab versus placebo
Strong demand for medications that show promise as treatments for COVID-19 have led to shortages of those drugs in the United States.

Shortages Seen for Drugs That Show Promise Against COVID-19

0
Patients who currently rely on remdesivir or hydroxychloroquine now facing dangerous shortages
Insulin and other biologic drugs

FDA: Insulin Among Drugs Transitioned to Biological Products

0
New regulatory pathway for biologic drugs allows for approval of biosimilars, interchangeable versions
A once-daily

Triple Therapy Cuts Mortality in Patients With Symptomatic COPD

0
All-cause mortality risk significantly lower for triple-drug regimen versus one of two dual-drug regimens
For adults with any of six chronic inflammatory diseases

Cumulative Dose of Oral Steroids Associated With HTN Incidence

0
Incidence of hypertension higher for adults on oral steroids for any of six chronic inflammatory diseases
From 2017 to 2018

CDC: Modest Decreases Seen in TB Cases, TB-Related Deaths

0
From 2017 to 2018, 2 and 5 percent declines seen in incident TB and TB-related deaths, respectively
Iron chelation therapy seems beneficial for iron-overloaded patients with low- or intermediate-1-risk myelodysplastic syndromes

Iron Chelation Therapy Treats Iron Overload in MDS

0
Event-free survival prolonged with ICT for patients with lower-risk myelodysplastic syndromes
From 2017 to 2018

2017 to 2018 Saw Drop in Overdose Death Rates Involving Opioids

0
But rates involving synthetic opioids increased